Biovault Technical

28/10/2026

Sustainability comes in many forms. Our fabulous new shipper racks come from long-term thinking about our energy, nitrogen and materials consumption and from collaborating with local experts on bespoke solutions that make every process easier and more satisfying.

23/10/2026

🩸 On the 25th October, World MDS Awareness Day highlights myelodysplastic syndromes (MDS), a group of bone marrow disorders that affect the production of healthy blood cells. For some patients with higher-risk MDS, allogeneic haematopoietic stem cell transplantation offers the only potentially curative treatment, although it is not suitable for everyone.

Research continues to improve understanding of these conditions, refine risk assessment and explore new treatment options. But progress depends on more than clinical research alone. Transplant pathways rely on donors, clinical teams, laboratories, carefully controlled processing and secure storage to ensure that cellular products are available when needed.

At Biovault Technical, we support the transplant community through specialist stem cell processing, storage and distribution, working with NHS partners to support safe and reliable care. This MDS Awareness Day, we recognise everyone contributing to better outcomes for people living with bone marrow disorders.

21/10/2026

CAR-T is making headlines, but it’s just one of many exciting approaches changing the future of cellular therapy. 🧬

From CAR-NK and TCR-T to tumour-infiltrating lymphocytes (TILs) and dendritic cell vaccines, researchers are exploring new ways to help the immune system recognise and fight cancer.

These therapies work in different ways, but there’s an important thing they have in common: cells need to be handled with care.

That’s where Biovault Technical comes in. We provide specialist cellular processing, cryopreservation, cryogenic storage and distribution, supporting the complex pathways that bring cellular therapies from the lab to clinical use.

Take a look at our infographic to discover some of the approaches shaping this fast-moving field.

19/10/2026

🤝 Living therapies need infrastructure you can trust.

Cell and gene therapies are advancing rapidly, and these complex, often time-critical treatments depend on specialist processing, reliable cryopreservation, secure storage and carefully controlled distribution.

Biovault Technical provides expertise, infrastructure and dependability.

Our services include:
• Haematopoietic stem cell processing, including PBSCs
• Immune effector cell processing and support for CAR-T pathways
• Cryopreservation and cryogenic storage
• Distribution, release and contingency solutions

With HTA licensing, JACIE accreditation and relevant MHRA authorisations, we work with NHS Trusts, clinical partners and research organisations to support the safe handling and delivery of cellular therapies.

As treatments evolve, the need for dependable, standards-led infrastructure remains.

Planning a cellular therapy pathway or reviewing your existing provision?

Talk to our team about how Biovault Technical can support your requirements.

https://www.biovaulttechnical.co.uk/insights-all/car-t-and-immune-effector-cell-therapies

15/10/2026

“The cleanroom is not a backdrop; it is a controlled variable.”

In cellular processing, the environment directly affects the outcome. Particle counts, pressure differentials and air quality aren't static background conditions; they are active parameters managed every second a product is in our care.

At Biovault Technical, our cleanroom infrastructure mitigates environmental risk at every stage, ensuring every unit meets the strictest regulatory and clinical JACIE, HTA, MHRA, HFEA and GMP standards.

Ensure your starting materials and final cell products are processed without compromise.

👉 Discover our GMP cell processing solutions: https://www.biovaulttechnical.co.uk/processing

13/10/2026

Treating leukaemia takes a village - from doctors and researchers to lab technicians and cell storage specialists. A new international study highlights how every step of a patient's journey impacts their cell therapy results.

Congratulations to the GoCART Coalition, The EBMT, Hospital Clínic de Barcelona, Valentin Ortiz-Maldonado and all co-authors on their latest publication in Blood Advances. 👏 This is vital work for the haematology and cellular therapy community, and we're proud to be part of the secure chain of care.

12/10/2026

We're looking forward to joining Miltenyi Biotec for two days of learning, sharing and connecting at Victoria House in London this week.

With exciting things happening in our R&D pipeline, our MD Ben Charles is looking forward to hearing from Rehma Chandaria from Cell and Gene Therapy Catapult, Dr Sandeep Kumar, Nicholas Moyse, Dr Sarah Albon MSc, Dr Roanne Jones Stuart Curbishley, Koki Lilova and Caitlyn Martin.

10/10/2026

Today is World Mental Health Day, and we felt it was a good time to celebrate our team doing something that has nothing to do with work: bowling. 🎳

Strikes, gutter balls and plenty of laughter. Nobody was counting scores (okay, maybe a few people were!).

We spend a lot of time with the people we work with, but how well do we really know them? Better work and better lives come when people feel supported, connected and able to switch off. Taking time to enjoy each other's company is an important part of what makes us a team.

Look after yourselves and each other today. 💙

hashtag hashtag hashtag hashtag

07/10/2026

Huge thanks to Maddie for sharing her story. People need to know that they can donate stem cells almost as easily as they can donate blood, and that this can change someone's life. Wishing you all the best for your recovery and career!

05/10/2026

When you think about how human cells and tissues are protected, you might think about cryogenic freezers. But what about digital security? ❄️📱

In advanced therapies, sample traceability and data governance are really the second cold chain. A data breach or lost audit trail can affect a clinical trial or patient therapy as seriously as a temperature spike.

Because Biovault Technical processes and stores human biological material for direct NHS partnerships, we build clinical-grade security into every step:

✅ Full Regulatory Integration: Aligned with HTA, MHRA, HFEA, JACIE, and NHS DSPT frameworks.
✅ Centralised LIMS Tracking: Real-time audit trails for complete sample accountability.
✅ Infrastructure Defence: Cyber Essentials Plus-accredited IT frameworks.

Are your processing workflows secured to clinical standards?

📩 Message our team today or visit our site to see how we support research and clinical teams: https://www.biovaulttechnical.co.uk/insights-all/data-security-biobanking

Discover how Biovault Technical delivers clinical-grade data security, combining NHS IG, HTA, and GDPR compliance to safeguard sensitive patient data.